152 related articles for article (PubMed ID: 38057688)
21. Hypothyroidism after radiotherapy for laryngeal cancer.
Kumpulainen EJ; Hirvikoski PP; Virtaniemi JA; Johansson RT; Simonen PM; Terävä MT; Asikainen RJ; Nykänen KJ; Kosma V
Radiother Oncol; 2000 Oct; 57(1):97-101. PubMed ID: 11033194
[TBL] [Abstract][Full Text] [Related]
22. Cancer-specific mortality in breast cancer patients with hypothyroidism: a UK population-based study.
McVicker L; Cardwell CR; McIntosh SA; McMenamin ÚC
Breast Cancer Res Treat; 2022 Sep; 195(2):209-221. PubMed ID: 35908274
[TBL] [Abstract][Full Text] [Related]
23. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
Bui KT; Willson ML; Goel S; Beith J; Goodwin A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
[TBL] [Abstract][Full Text] [Related]
24. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.
Galper S; Gelman R; Recht A; Silver B; Kohli A; Wong JS; Van Buren T; Baldini EH; Harris JR
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):406-14. PubMed ID: 11872286
[TBL] [Abstract][Full Text] [Related]
25. Increased risk for hypothyroidism after anticholinesterase pesticide poisoning: a nationwide population-based study.
Huang HS; Lee KW; Ho CH; Hsu CC; Su SB; Wang JJ; Lin HJ; Huang CC
Endocrine; 2017 Sep; 57(3):436-444. PubMed ID: 28756521
[TBL] [Abstract][Full Text] [Related]
26. Risk of Breast Cancer in Females With Hypothyroidism: A Nationwide, Population-Based, Cohort Study.
Huang CH; Wei JC; Chien TC; Kuo CW; Lin SH; Su YC; Hsu CY; Chiou JY; Yeh MH
Endocr Pract; 2021 Apr; 27(4):298-305. PubMed ID: 33779560
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcome after postmastectomy radiation therapy for breast cancer patients at high risk for local-regional recurrence.
Metz JM; Schultz DJ; Fox K; Glick J; Solin LJ
Cancer J Sci Am; 1999; 5(2):77-83. PubMed ID: 10198729
[TBL] [Abstract][Full Text] [Related]
28. Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension.
Evron E; Barzily L; Rakowsky E; Ben-Baruch N; Sulkes J; Rizel S; Fenig E
Isr Med Assoc J; 2005 Jul; 7(7):439-42. PubMed ID: 16011059
[TBL] [Abstract][Full Text] [Related]
29. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
[TBL] [Abstract][Full Text] [Related]
30. Liothyronine Use in Hypothyroidism and its Effects on Cancer and Mortality.
Planck T; Hedberg F; Calissendorff J; Nilsson A
Thyroid; 2021 May; 31(5):732-739. PubMed ID: 33040688
[No Abstract] [Full Text] [Related]
31. Second malignancies after adjuvant radiation therapy for early stage breast cancer: is there increased risk with addition of regional radiation to local radiation?
Hamilton SN; Tyldesley S; Li D; Olson R; McBride M
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):977-85. PubMed ID: 25832690
[TBL] [Abstract][Full Text] [Related]
32. Dose-volumetric parameters for predicting hypothyroidism after radiotherapy for head and neck cancer.
Kim MY; Yu T; Wu HG
Jpn J Clin Oncol; 2014 Apr; 44(4):331-7. PubMed ID: 24482412
[TBL] [Abstract][Full Text] [Related]
33. T1-T2 breast cancer with four or more positive axillary lymph nodes: adjuvant locoregional radiotherapy with high-dose or standard-dose chemotherapy. Results of an observational study.
Perrucci E; Aristei C; De Angelis V; Anselmo P; Mascioni F; Gori S; Frattegiani A; Latini P
Tumori; 2004; 90(4):379-86. PubMed ID: 15510979
[TBL] [Abstract][Full Text] [Related]
34. Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study.
Plym A; Johansson ALV; Bower H; Wennstig AK; Fredriksson I; Ahlgren J; Lambe M
Breast Cancer Res Treat; 2020 Aug; 182(3):699-707. PubMed ID: 32506337
[TBL] [Abstract][Full Text] [Related]
35. Predictive factors for thyroid complications after radiation therapy-data from a cohort of cancer patients closely followed since they were irradiated.
Duarte V; Maciel J; Cavaco D; Donato S; Damásio I; Pinheiro S; Figueiredo A; Ferreira A; Pereira JS
Clin Endocrinol (Oxf); 2022 May; 96(5):728-733. PubMed ID: 34978354
[TBL] [Abstract][Full Text] [Related]
36. Is thyroid gland an organ at risk in breast cancer patients treated with locoregional radiotherapy? Results of a pilot study.
Tunio MA; Al Asiri M; Bayoumi Y; Stanciu LG; Al Johani N; Al Saeed EF
J Cancer Res Ther; 2015; 11(4):684-9. PubMed ID: 26881502
[TBL] [Abstract][Full Text] [Related]
37. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
[TBL] [Abstract][Full Text] [Related]
38. Primary and central hypothyroidism after radiotherapy for head-and-neck tumors.
Bhandare N; Kennedy L; Malyapa RS; Morris CG; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1131-9. PubMed ID: 17446000
[TBL] [Abstract][Full Text] [Related]
39. Primary hypothyroidism in breast cancer patients with irradiated supraclavicular lymph nodes.
Bruning P; Bonfrèr J; De Jong-Bakker M; Nooyen W; Burgers M
Br J Cancer; 1985 May; 51(5):659-63. PubMed ID: 3994909
[TBL] [Abstract][Full Text] [Related]
40. Breast Cancer Risk in Postmenopausal Women with Medical History of Thyroid Disorder in the Women's Health Initiative.
Weng CH; Okawa ER; Roberts MB; Park SK; Umbricht CB; Manson JE; Eaton CB
Thyroid; 2020 Apr; 30(4):519-530. PubMed ID: 31918623
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
